People could get the right help for the diseases that can cause dementia sooner following the announcement today of a \u00a32 million injection of funding from the government to help spot these earlier.
A new service development project, run by Dementias Platform UK (DPUK) supported under a Collaborative Working Agreement by Eli Lilly and Company and Oxford Health NHS Foundation Trust has been launched at the Oxford Health Clinical Research Facility (OH CRF).
It's been ten years since Dementias Platform UK first launched back in the autumn of 2014. We hear from some of those who were there when it all started as they give their assessment of what's been accomplished.
Dementias Platform UK is ten years old. We launched in 2014 and have over the decade built an infrastructure which has enabled wide-ranging research and brought together a collaborative community in dementia research. During the 2024 Clinical Trials on Alzheimer's Disease (CTAD) conference, Professor John Gallacher was reflecting on a decade of hard work by the large team past and present at DPUK.
This week Donanemab, a second new treatment that slows the progression of Alzheimer\u2019s disease has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) but deemed too expensive by the National Institute for Health and Care Excellence (NICE) for widespread use in the NHS. At the same time, DPUK gathered in Nottingham for the latest in our Great Minds events to consider, in the absence of and in addition to accessible treatments, how can you live well with dementia?
DPUK is committed to internationalising access to datasets. Professor John Gallacher recently addressed a Summit in Washington DC about the high value of data sharing to advance dementia research.
Our DPUK team from AAIC 24 is regrouping now after a very busy week covering lots of ground. We asked a few of them to tell us their personal highlights and share the big news stories to emerge.
Research into the life-shortening neurological condition motor neurone disease (MND) will receive a major boost through the formation of a new data catalyst led by Dementias Platform UK (DPUK) and Health Data Research UK (HDR UK).
Dementias Platform UK recently welcomed the dementia research community to London for two days packed full of research updates, collaboration and networking at the Translation 2024 conference.
There is a huge focus right now around improving dementia diagnosis rates. Part of the work we\u2019re doing here at DPUK enables researchers to identify biomarkers which may be able to detect the risk of dementia earlier, confirmed by a simple blood test. This could be transformational in speeding up and improving the diagnostic process.
Our rapidly growing register of healthy volunteers, Great Minds, is holding its next live event on May 16th. The focus is on language, learning and music.
One of our speakers at Great Minds Live on May 16th in Sheffield (and for hundreds more online), is Professor Carol Holland. She has been studying ageing health psychology and frailty throughout her career. Carol is Director of the Centre for Ageing Research at Lancaster University and is currently President of the British Society of Gerontology.
The second day of #Translation2024 began with a personal account of living with mild cognitive impairment before we dived into the complexity of data and AI.
There has never been such a high level of focus on biomarkers as we have today. It's fitting that Translation 2024 began with a look into the exciting developments which are emerging from this wave of research.
Dementias Platform UK has been awarded over \u00a34 million to carry out countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve the UK\u2019s shocking diagnosis rate.
This week the DPUK executive team were thrilled to visit Downing Street to join a meeting focused on speeding up dementia research as part of the Dame Barbara Windsor Dementia Mission.
![\"\"](\"https://www.dementiasplatform.uk/news-and-media/latest-news/digital-test-is-a-boost-to-read-out-biomarker-study-into-effective-ways-of-spotting-dementia-sooner/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n